Peptide tyrosine tyrosine (PYY) as a new strategy for treating obesity
Background Obesity is a risk factor for obesity-related disorders such as type 2 diabetes mellitus, vascular disease, osteoarthritis, sleep apnea, and malignancy. Obesity cohinder the individual work capacity, and the cost for managing obesity complications is high. Objective The objective of this r...
Saved in:
Main Author: | Ahmed Mostafa Mahmoud (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis
by: Jozsef A. Balog, et al.
Published: (2021) -
From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond
by: Yu Zhou, et al.
Published: (2024) -
Morphological study of remineralization of the eroded enamel lesions by tyrosine-rich amelogenin peptide
by: Mingzhu Wen, et al.
Published: (2024) -
Tyrosine kinases in rheumatoid arthritis
by: Kobayashi Akiko, et al.
Published: (2011) -
Tyrosine kinase inhibition: the new front in HIV cure efforts
by: V. Planelles, et al.
Published: (2019)